Acute visual dysfunction following Phenytoin induced Toxicity
Downloads
Published
Keywords:
Acute phenytoin toxicity, Ocular manifestation, Symblepharon, SJS-Steven Johnson Syndrome.Dimensions Badge
Issue
Section
License
Copyright (c) 2021 UP Journal of Ophthalmology
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
© UPJO, 2023 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit https://creativecommons.org/licenses/by-nc-sa/4.0/.
Abstract
Aim: Acute Visual Dysfunction may be caused by Acute Phenytoin Toxicity
Method: An 18 year old female with prior generalized tonic-clonic seizures developed blurred vision, diffuse
corneal opacity (OD), and ankyloblepharon after Phenytoin administration for seizures. Colour vision was
found to be normal with Ishihara pseudo-isochromatic charts and visual fields (Humphrey's automated
perimeter) show gross concentric constriction in both eyes. Fundus examination revealed increased CD ratio in
both eyes. Patient also developed multiple cutaneous maculo-papular lesions and Steven-Johnson syndrome
like exfoliation of skin around lips and perioral area. Serum free-phenytoin concentration measured reveals
toxic levels of Phenytoin with no other prior co-morbid retinopathy or optic nerve defect.
Results: Phenytoin was withheld, and Leviteracetam administered for seizures and the patient experienced a
partial recovery in skin lesions with administration of Prednisolone and in conjunction with reducing serum
levels of Phenytoin. Two weeks later the skin lesions have partially subsided, perioral area healed but Bilateral
Ankyloblepharon persists and surgical release may be advised.
Conclusion: Phenytoin toxicity may cause acute visual dysfunction as previously unknown phenomenon.
How to Cite
Downloads